サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672221

HbA1c検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測

Global HbA1c Testing Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 214 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
HbA1c検査の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2025年から2033年までの予測
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 214 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

HbA1c検査の世界市場規模は、2024年の22億2,000万米ドルから2033年には62億7,000万米ドルに成長し、2026～2033年の予測期間中に12.2％の堅調な年間平均成長率（CAGR）を示すと予測されます。

HbA1c検査市場は、糖尿病有病率の上昇と予防医療重視の高まりに牽引され、大きく成長する展望です。医療プロバイダーが糖尿病の早期診断と管理に注力する中、HbA1c検査は長期的なグルコースコントロールをモニタリングするための重要なツールとして台頭してきました。この検査は糖尿病の診断を助けるだけでなく、治療レジメンの有効性を評価する上でも重要な役割を果たしており、糖尿病治療において不可欠なものとなっています。

診断検査における技術の進歩は、HbA1c検査の展望を再構築しています。ポイントオブケア検査機器の革新は、アクセス性と利便性を高め、患者がより効果的にグルコース値をモニターできるようにしています。これらの機器は迅速な結果を提供し、タイムリーな介入と個別化された治療計画を可能にします。さらに、モバイルアプリケーションや遠隔医療などのデジタルヘルスソリューションの統合により、患者のエンゲージメント向上と治療プロトコルの遵守が促進され、全体的な健康アウトカムが改善されています。

糖尿病管理の重要性に対する意識の高まりも市場拡大の原動力となっています。コントロールされていない糖尿病に関連するリスクについて個人を教育することを目的とした公衆衛生イニシアチブは、より多くの人々が定期的な検査を受けるよう促しています。医療システムが金額ベースのケアを優先するようになるにつれ、信頼性が高く正確なHbA1c検査ソリューションに対する需要が高まることが予想されます。このような進化する環境において、利害関係者はHbA1c検査市場の成長ポテンシャルを活用し、イノベーションを推進し、その過程で患者ケアを向上させることができる立場にあります。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察を顧客に提供するために綿密に作成されています。各レポートは、市場情勢を完全に理解するために、いくつかの重要な要素を含んでいます。

市場概要：市場概要：定義、分類、産業の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主要促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場参入企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を記載しています。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域による市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネス機会を理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象セグメントを特定します。将来の市場開拓と成長展望に関する洞察を記載しています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 HbA1c検査産業の分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 産業動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原料分析
    • 原料リスト
    • 原料メーカー一覧
    • 主要原料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 HbA1c検査の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 製品タイプ別過去・予測データ分析
  • 検査機器
  • 試薬
  • キット

第6章 HbA1c検査の世界市場分析：技術別

  • 技術別概要
  • 技術別過去・予測データ分析
  • イオン交換HPLC
  • 酵素アッセイ
  • アフィニティ結合クロマトグラフィー
  • 比濁阻害免疫測定法
  • その他

第7章 HbA1c検査の世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • エンドユーザー別過去・予測データ分析
  • 病院とクリニック
  • 診断ラボ
  • 在宅医療
  • 研究機関
  • その他

第8章 HbA1c検査の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別一覧
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 HbA1c検査企業の競合情勢

  • HbA1c検査市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品の発売
  • その他の開発

第10章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Abbott
  • Bio-Rad Laboratories Inc.
  • ARKRAY Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH
  • TransAsia Bio-Medicals
  • Trinity BIoTech Ireland
  • EKF Diagnostics
  • Randox Laboratories Ltd.
  • HemoCue India
  • Eurolyser Diagnostica GmbH
  • Sekisui Diagnostics
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product Type (Units and USD MN)
  • Instruments Market Sales By Geography (Units and USD MN)
  • Reagents Market Sales By Geography (Units and USD MN)
  • Kits Market Sales By Geography (Units and USD MN)
  • Analysis By Technology (Units and USD MN)
  • Ion-exchange HPLC Market Sales By Geography (Units and USD MN)
  • Enzymatic assay Market Sales By Geography (Units and USD MN)
  • Affinity binding chromatography Market Sales By Geography (Units and USD MN)
  • Turbidimetric inhibition immunoassay Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Analysis By End User (Units and USD MN)
  • Hospitals and clinics Market Sales By Geography (Units and USD MN)
  • Diagnostic laboratories Market Sales By Geography (Units and USD MN)
  • Homecare Market Sales By Geography (Units and USD MN)
  • Research institution Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global HbA1c Testing Market Sales By Geography (Units and USD MN)
  • North America Market Analysis (Units and USD MN)
  • United States Market Analysis (Units and USD MN)
  • Canada Market Analysis (Units and USD MN)
  • Mexico Market Analysis (Units and USD MN)
  • Europe Market Analysis (Units and USD MN)
  • Europe Market Estimate By Country (Units and USD MN)
  • United Kingdom Market Analysis (Units and USD MN)
  • France Market Analysis (Units and USD MN)
  • Germany Market Analysis (Units and USD MN)
  • Italy Market Analysis (Units and USD MN)
  • Russia Market Analysis (Units and USD MN)
  • Spain Market Analysis (Units and USD MN)
  • Rest of Europe Market Analysis (Units and USD MN)
  • Asia Pacific Market Analysis (Units and USD MN)
  • China Market Analysis (Units and USD MN)
  • Japan Market Analysis (Units and USD MN)
  • India Market Analysis (Units and USD MN)
  • South Korea Market Analysis (Units and USD MN)
  • Australia Market Analysis (Units and USD MN)
  • South East Asia Market Analysis (Units and USD MN)
  • Rest of Asia Pacific Market Analysis (Units and USD MN)
  • Latin America Market Analysis (Units and USD MN)
  • Brazil Market Analysis (Units and USD MN)
  • Argentina Market Analysis (Units and USD MN)
  • Peru Market Analysis (Units and USD MN)
  • Chile Market Analysis (Units and USD MN)
  • Rest of Latin America Market Analysis (Units and USD MN)
  • Middle East & Africa Market Analysis (Units and USD MN)
  • Saudi Arabia Market Analysis (Units and USD MN)
  • UAE Market Analysis (Units and USD MN)
  • Israel Market Analysis (Units and USD MN)
  • South Africa Market Analysis (Units and USD MN)
  • Rest of Middle East and Africa Market Analysis (Units and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of HbA1c Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global HbA1c Testing Market Size, By Region (Units and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product Type
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product Type (Units and USD MN)
  • Instruments Market Sales By Geography (Units and USD MN)
  • Reagents Market Sales By Geography (Units and USD MN)
  • Kits Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By Technology (Units and USD MN)
  • Ion-exchange HPLC Market Sales By Geography (Units and USD MN)
  • Enzymatic assay Market Sales By Geography (Units and USD MN)
  • Affinity binding chromatography Market Sales By Geography (Units and USD MN)
  • Turbidimetric inhibition immunoassay Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Market Analysis By End User (Units and USD MN)
  • Hospitals and clinics Market Sales By Geography (Units and USD MN)
  • Diagnostic laboratories Market Sales By Geography (Units and USD MN)
  • Homecare Market Sales By Geography (Units and USD MN)
  • Research institution Market Sales By Geography (Units and USD MN)
  • Others Market Sales By Geography (Units and USD MN)
  • Global Market Sales (Units and USD MN)
  • North America Market Sales (Units and USD MN)
  • Europe Market Sales (Units and USD MN)
  • Asia Pacific Market Sales (Units and USD MN)
  • Latin America Market Sales (Units and USD MN)
  • Middle East & Africa Market Sales (Units and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11210079

Global HbA1c Testing Market size is anticipated to grow from USD 2.22 Billion in 2024 to USD 6.27 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 12.2% during the forecast period of 2026 to 2033.

The HbA1c testing market is poised for significant growth, driven by the rising prevalence of diabetes and the increasing emphasis on preventive healthcare. As healthcare providers focus on early diagnosis and management of diabetes, HbA1c testing has emerged as a critical tool for monitoring long-term glucose control. This test not only aids in the diagnosis of diabetes but also plays a vital role in assessing the effectiveness of treatment regimens, making it indispensable in diabetes care.

Technological advancements in diagnostic testing are reshaping the HbA1c testing landscape. Innovations in point-of-care testing devices are enhancing accessibility and convenience, allowing patients to monitor their glucose levels more effectively. These devices provide rapid results, enabling timely interventions and personalized treatment plans. Furthermore, the integration of digital health solutions, such as mobile applications and telemedicine, is facilitating better patient engagement and adherence to treatment protocols, thereby improving overall health outcomes.

The growing awareness of the importance of diabetes management is also driving market expansion. Public health initiatives aimed at educating individuals about the risks associated with uncontrolled diabetes are prompting more people to seek regular testing. As healthcare systems increasingly prioritize value-based care, the demand for reliable and accurate HbA1c testing solutions is expected to rise. In this evolving environment, stakeholders are well-positioned to capitalize on the growth potential of the HbA1c testing market, driving innovation and improving patient care in the process.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

  • Instruments
  • Reagents
  • Kits

By Technology

  • Ion-exchange HPLC
  • Enzymatic assay
  • Affinity binding chromatography
  • Turbidimetric inhibition immunoassay
  • Others

By End User

  • Hospitals and clinics
  • Diagnostic laboratories
  • Homecare
  • research institution
  • others
  • COMPANIES PROFILED
  • Abbott
  • Bio-Rad Laboratories Inc.
  • ARKRAY Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare GmbH
  • TransAsia Bio-Medicals
  • Trinity Biotech Ireland
  • EKF Diagnostics
  • Randox Laboratories Ltd.
  • HemoCue India
  • Eurolyser Diagnostica GmbH
  • Sekisui Diagnostics
  • Healio
  • Diazyme Laboratories Inc.
  • Beckman Coulter Inc.
  • A. Menarini Diagnostics srl
  • SEBIA
  • PTS Diagnostics
  • DiaSys Diagnostic Systems GmbH.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HBA1C TESTING INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Technology
    • 3.7.3 Market Attractiveness Analysis By End User
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HBA1C TESTING MARKET ANALYSIS BY PRODUCT TYPE

  • 5.1. Overview By Product Type
  • 5.2. Historical and Forecast Data Analysis By Product Type
  • 5.3. Instruments Historic and Forecast Sales By Regions
  • 5.4. Reagents Historic and Forecast Sales By Regions
  • 5.5. Kits Historic and Forecast Sales By Regions

6. GLOBAL HBA1C TESTING MARKET ANALYSIS BY TECHNOLOGY

  • 6.1. Overview By Technology
  • 6.2. Historical and Forecast Data Analysis By Technology
  • 6.3. Ion-exchange HPLC Historic and Forecast Sales By Regions
  • 6.4. Enzymatic assay Historic and Forecast Sales By Regions
  • 6.5. Affinity binding chromatography Historic and Forecast Sales By Regions
  • 6.6. Turbidimetric inhibition immunoassay Historic and Forecast Sales By Regions
  • 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL HBA1C TESTING MARKET ANALYSIS BY END USER

  • 7.1. Overview By End User
  • 7.2. Historical and Forecast Data Analysis By End User
  • 7.3. Hospitals and clinics Historic and Forecast Sales By Regions
  • 7.4. Diagnostic laboratories Historic and Forecast Sales By Regions
  • 7.5. Homecare Historic and Forecast Sales By Regions
  • 7.6. Research institution Historic and Forecast Sales By Regions
  • 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL HBA1C TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HBA1C TESTING COMPANIES

  • 9.1. HbA1c Testing Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF HBA1C TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Abbott
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Bio-Rad Laboratories Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. ARKRAY Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. Danaher
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. F. Hoffmann-La Roche Ltd.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. Siemens Healthcare GmbH
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments
  • 10.9. TransAsia Bio-Medicals
    • 10.9.1 Company Overview
    • 10.9.2 Company Revenue
    • 10.9.3 Products
    • 10.9.4 Recent Developments
  • 10.10. Trinity Biotech Ireland
    • 10.10.1 Company Overview
    • 10.10.2 Company Revenue
    • 10.10.3 Products
    • 10.10.4 Recent Developments
  • 10.11. EKF Diagnostics
    • 10.11.1 Company Overview
    • 10.11.2 Company Revenue
    • 10.11.3 Products
    • 10.11.4 Recent Developments
  • 10.12. Randox Laboratories Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Revenue
    • 10.12.3 Products
    • 10.12.4 Recent Developments
  • 10.13. HemoCue India
    • 10.13.1 Company Overview
    • 10.13.2 Company Revenue
    • 10.13.3 Products
    • 10.13.4 Recent Developments
  • 10.14. Eurolyser Diagnostica GmbH
    • 10.14.1 Company Overview
    • 10.14.2 Company Revenue
    • 10.14.3 Products
    • 10.14.4 Recent Developments
  • 10.15. Sekisui Diagnostics
    • 10.15.1 Company Overview
    • 10.15.2 Company Revenue
    • 10.15.3 Products
    • 10.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies